Study of Pemetrexed and Gemcitabine for Patients With a New Diagnosis of Extensive-Stage Small Cell Lung Cancer
Status:
Terminated
Trial end date:
2006-10-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine whether pemetrexed and gemcitabine cause good tumour
shrinkage when given to patients with previously untreated extensive-stage small cell lung
cancer. The second purpose is to see if the side effects appear better than what is expected
with standard chemotherapy.